Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common cancers world‐wide but the molecular mechanisms that underlie hepatocarcinogenesis are not fully determined. On the same surgical sample with HCC, we performed microarray‐based gene expression profiling and karyotype analysis using a single nucleotide polymorphism (SNP) array. In addition, quantitative real‐time reverse transcription polymerase chain reaction (PCR), methylation specific PCR (MSP) and immunohistochemical staining were conducted using specimens from 48 patients with HCC. Gene expression profiling showed the expression of fibulin 1 (FBLN1), located on 22q13, to be decreased in tumor tissue. Karyotype analysis revealed no loss of heterozygosity (LOH) since deletions were not detected in 22q, and one of the SNPs on 22q13 showed AB genotype in both cancerous tissue and in corresponding noncancerous tissue, indicating retention of heterozygosity. Quantitative real‐time PCR showed FBLN1 mRNA levels in cancerous tissues to be significantly decreased compared with that in corresponding noncancerous tissues. The immunohistochemical staining results were consistent with both gene expression profiling and quantitative PCR data. Twenty‐four out of 48 HCCs gave a positive result in MSP. Moreover, promoter hypermethylation of FBLN1 was significantly associated with advanced stage HCC, multiple tumors and increased tumor size. Our results indicated that FBLN1 is a novel candidate of tumor suppressor gene and that promoter hypermethylation of FBLN1 is associated with tumor progression in HCC. © 2011 Wiley‐Liss, Inc.

[1]  M. Kanda,et al.  Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1, EFEMP1, a Novel Tumor-Suppressor Gene Detected in Hepatocellular Carcinoma Using Double Combination Array Analysis , 2010, Annals of Surgical Oncology.

[2]  Mark S. Boguski,et al.  Biomedical informatics for proteomics , 2003, Nature.

[3]  L. Terracciano,et al.  NY‐ESO‐1/LAGE‐1 coexpression with MAGE‐A cancer/testis antigens: A tissue microarray study , 2005, International journal of cancer.

[4]  Kenji Yokoyama,et al.  Self‐assembly DNA‐conjugated polymer for detection of single nucleotide polymorphism , 2004, Biotechnology and bioengineering.

[5]  M. Kanda,et al.  Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis. , 2009, International journal of oncology.

[6]  Jun Yu,et al.  Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer , 2008, British Journal of Cancer.

[7]  C. Little,et al.  Identification of chicken and C. elegans fibulin-1 homologs and characterization of the C. elegans fibulin-1 gene. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[8]  S. Ménard,et al.  Regulation of breast cancer response to chemotherapy by fibulin-1. , 2007, Cancer research.

[9]  D. Katsaros,et al.  Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells , 2002, Oncogene.

[10]  M. Kanda,et al.  Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array. , 2010, Cancer letters.

[11]  Andrea Tannapfel,et al.  Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays , 2003, The Journal of pathology.

[12]  Rameen Beroukhim,et al.  Single nucleotide polymorphism array analysis of cancer , 2007, Current opinion in oncology.

[13]  Cisca Wijmenga,et al.  Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays. , 2005, Cancer research.

[14]  Jian-Min Yuan,et al.  Environmental factors and risk for hepatocellular carcinoma. , 2004, Gastroenterology.

[15]  W. Lau,et al.  Hepatocellular carcinoma: current management and recent advances. , 2008, Hepatobiliary & pancreatic diseases international : HBPD INT.

[16]  Robert P. Thompson,et al.  Fibulin-1 is required for morphogenesis of neural crest-derived structures. , 2008, Developmental biology.

[17]  M. Cusnir,et al.  Novel Systemic Therapy Options for Hepatocellular Carcinoma , 2004, Cancer journal.

[18]  Alexander E. Dityatev,et al.  Extracellular matrix and synaptic functions. , 2006, Results and problems in cell differentiation.

[19]  Xiaohong Liu,et al.  Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses , 2008, Carcinogenesis.

[20]  H. Hakonarson,et al.  Microarray technology and applications in the arena of genome-wide association. , 2008, Clinical chemistry.

[21]  R. Margueron,et al.  Transcriptional and posttranscriptional regulation of fibulin-1 by estrogens leads to differential induction of messenger ribonucleic acid variants in ovarian and breast cancer cells. , 2005, Endocrinology.

[22]  R. Timpl,et al.  Fibulins: a versatile family of extracellular matrix proteins , 2003, Nature Reviews Molecular Cell Biology.

[23]  M. Durbeej,et al.  Role of the extracellular matrix and its receptors in smooth muscle cell function: implications in vascular development and disease , 2007, Current opinion in lipidology.

[24]  Wolfgang A. Schulz,et al.  Downregulation of several fibulin genes in prostate cancer , 2007, The Prostate.

[25]  S. Ménard,et al.  Immunological and pathobiological roles of fibulin-1 in breast cancer , 2004, Oncogene.

[26]  E. Papoutsakis,et al.  Microarray‐based gene expression analysis as a process characterization tool to establish comparability of complex biological products: Scale‐up of a whole‐cell immunotherapy product , 2009, Biotechnology and bioengineering.

[27]  E. Ruoslahti,et al.  Fibulin, a novel protein that interacts with the fibronectin receptor β subunit cytoplasmic domain , 1989, Cell.

[28]  Y. Yamada,et al.  Fibulins: Multiple roles in matrix structures and tissue functions , 2009, Cellular and Molecular Life Sciences.

[29]  Kenneth M. Yamada,et al.  The matrix reorganized: extracellular matrix remodeling and integrin signaling. , 2006, Current opinion in cell biology.